Pattern and Incidence of Covid-19 Vaccine Reactions among Adult Clients in a Tertiary Health Facility in a North-Central State of Nigeria
DOI:
https://doi.org/10.31674/mjn.2024.v16i01.002Abstract
Introduction: As a result of the rapid development and approval of the COVID-19 vaccine during the pandemic, there was serious misinformation about the safety of the COVID-19 vaccine. Providing evidence-based proof of the safety of the COVID-19 vaccine could dispel this scepticism. The study aimed to assess the pattern and incidence of COVID-19 vaccine reactions among adult clients in a tertiary health facility following immunization. Methods: The cross-sectional study was conducted in a tertiary care institute among recipients of the first dose of the of the COVID-19 vaccine between April and July 2021. Study populations were adults above 18 years. Participants were assessed for any reactions four times. Immediately after vaccination and later, same day one, day 2, day 3, and on/after day 7. A telephone interview was conducted, and the recipients were assessed according to the time and type of reactions, actions taken following reactions, and severe forms of reactions. Results: A total of 1535 participants were assessed post-COVID-19 vaccination reactions, and 805 (52.4%) reported at least one of the COVID-19 vaccine reactions following vaccination, and less than a percent reported perceived severe adverse reactions. Pain at the injection site (5.0%), myalgia (2.8%), and headache (1.6%) were the common adverse events reported immediately after vaccination. The majority of the respondents (93.4%) were willing to take the second dose of the of the COVID-19 vaccine. The major factor associated with COVID-19 vaccine reactions following vaccination was the age group. Conclusion: Many people still experience a certain type of discomfort after vaccinations; this discomfort is often mild to moderate and is more prevalent in young adults. Most of the reactions resolve after a few days without intervention.
Keywords:
Adverse Events, COVID-19, Vaccines and Vaccine ReactionsDownloads
References
Adamu, H., Lawal, S., Bawa, I. A., Sani, A. M., & Adamu, A. A. (2022). Prevalence and pattern of adverse events following COVID 19 vaccination among adult population in Sokoto metropolis, northwest, Nigeria. MedRxiv, 2022-11. https://doi.org/10.1101/2022.11.01.22281793
Ahmed, M. H., Siraj, S. S., Klein, J., Ali, F. Y., & Kanfe, S. G. (2021). Knowledge and attitude towards second COVID-19 vaccine dose among health professionals working at public health facilities in a low income country. Infection and Drug Resistance, 3125-3134. https://doi.org/10.2147/IDR.S327954
Allagoa, D. O., Oriji, P. C., Tekenah, E. S., Obagah, L., Njoku, C., Afolabi, A. S., & Atemie, G. (2021). Predictors of acceptance of COVID-19 vaccine among patients at a tertiary hospital in South-South Nigeria. International Journal of Community Medicine and Public Health, 8(5), 2165-72. https://dx.doi.org/10.18203/2394-6040.ijcmph20211733
Arsenault, C., Lewis, T. P., Kapoor, N. R., Okiro, E. A., Leslie, H. H., Armeni, P., ... & Kruk, M. E. (2024). Health system quality and COVID-19 vaccination: a cross-sectional analysis in 14 countries. The Lancet Global Health, 12(1), e156-e165. https://doi.org/10.1016/S2214-109X(23)00490-4
Byrne, P. O., & McLellan, J. S. (2022). Principles and practical applications of structure-based vaccine design. Current Opinion in Immunology, 77, 102209. https://doi.org/10.1016/j.coi.2022.102209
Callaway, E. (2020). The race for coronavirus vaccines: a graphical guide. Nature, 580(7805), 576-577. https://doi.org/10.1038/d41586-020-01221-y
Chu, D. T., Vu Thi, H., Nguyen Thi, Y. V., Nguyen, M. A., Bui, N. L., Hoang, V. T., ... & Al-Tawfiq, J. A. (2023). Willingness to receive COVID-19 vaccine booster doses for adults and their children in Vietnam. Journal of Human Behavior in the Social Environment, 33(2), 212-224. https://pesquisa.bvsalud.org/global-literature-on-novel-coronavirus-2019-ncov/resource/pt/covidwho-222895
Accessed on 11th June, 2023.
Dele-Ojo, B. F., Adesokan, A., Fadare, J. O., Ajayi, P. O., Raimi, T. H., Dada, S. A., ... & Godman, B. (2024). Short-term COVID-19 vaccine adverse effects among adults in Ekiti State, Nigeria. Current Medical Research and Opinion, 40(4), 621-627. https://doi.org/10.1080/03007995.2024.2316217
Demuyakor, J., Nyatuame, I. N., & Obiri, S. (2021). Unmasking covid-19 vaccine “infodemic” in the social media. Online Journal of Communication and Media Technologies, 11(4), e202119. https://doi.org/10.30935/ojcmt/11200
Elnaem, M. H., Mohd Taufek, N. H., Ab Rahman, N. S., Mohd Nazar, N. I., Zin, C. S., Nuffer, W., & Turner, C. J. (2021). COVID-19 vaccination attitudes, perceptions, and side effect experiences in Malaysia: do age, gender, and vaccine type matter?. Vaccines, 9(10), 1156. https://doi.org/10.3390/vaccines9101156
Gee, J., Shimabukuro, T. T., Su, J. R., Shay, D., Ryan, M., Basavaraju, S. V., ... & Anderson, S. (2024). Overview of US COVID-19 vaccine safety surveillance systems. Vaccine. https://doi.org/10.1016/j.vaccine.2024.02.065
Harry, A. M., Edet, C. K., Ekanem, N. E., Kemdirim, C. J., & Uduak, A. E. (2022). Adverse events following COVID-19 vaccination in Rivers State, Nigeria: a cross-sectional study. Nigerian Postgraduate Medical Journal, 29(2), 89-95. https://doi.org/10.4103/npmj.npmj_11_22
Hernandez, R. G., Hagen, L., Walker, K., O’Leary, H., & Lengacher, C. (2021). The COVID-19 vaccine social media infodemic: healthcare providers’ missed dose in addressing misinformation and vaccine hesitancy. Human Vaccines & Immunotherapeutics, 17(9), 2962-2964. https://doi.org/10.1080/21645515.2021.1912551
Hsieh, C. L., Goldsmith, J. A., Schaub, J. M., DiVenere, A. M., Kuo, H. C., Javanmardi, K., ... & McLellan, J. S. (2020). Structure-based design of prefusion-stabilized SARS-CoV-2 spikes. Science, 369(6510), 1501-1505. https://doi.org/10.1126/science.abd0826
Ingram, C., Roe, M., Downey, V., Phipps, L., & Perrotta, C. (2023). Exploring key informants’ perceptions of Covid-19 vaccine hesitancy in a disadvantaged urban community in Ireland: Emergence of a ‘4Cs’ model. Vaccine, 41(2), 519-531. https://doi.org/10.1016/j.vaccine.2022.11.072
Jeon, M., Kim, J., Oh, C. E., & Lee, J. Y. (2021). Adverse events following immunization associated with coronavirus disease 2019 vaccination reported in the mobile vaccine adverse events reporting system. Journal of Korean Medical Science, 36(17). https://doi.org/10.3346/jkms.2021.36.e114
Kadali, R. A. K., Janagama, R., Peruru, S., Gajula, V., Madathala, R. R., Chennaiahgari, N., & Malayala, S. V. (2021). Non‐life‐threatening adverse effects with COVID‐19 mRNA‐1273 vaccine: A randomized, cross‐sectional study on healthcare workers with detailed self‐reported symptoms. Journal of Medical Virology, 93(7), 4420-4429. https://doi.org/10.1002/jmv.26996
Kamoka, H. M. E., & Elengoe, A. (2024). An Investigation on Use of Traditional Medicine during COVID-19 and Post-COVID-19. International Journal of Advancement in Life Sciences Research, 7(1), 89-102. https://doi.org/10.31632/ijalsr.2024.v07i01.010
Karlsson, L. C., Soveri, A., Lewandowsky, S., Karlsson, L., Karlsson, H., Nolvi, S., ... & Antfolk, J. (2021). Fearing the disease or the vaccine: The case of COVID-19. Personality and Individual Differences, 172, 110590. https://doi.org/10.1016/j.paid.2020.110590
Malik, A. A., McFadden, S. M., Elharake, J., & Omer, S. B. (2020). Determinants of COVID-19 vaccine acceptance in the US. EClinicalMedicine, 26. https://doi.org/10.1016/j.eclinm.2020.100495
Mathieu, E., Ritchie, H., Ortiz-Ospina, E., Roser, M., Hasell, J., Appel, C., ... & Rodés-Guirao, L. (2021). A global database of COVID-19 vaccinations. Nature Human Behaviour, 5(7), 947-953. https://doi.org/10.1038/s41562-021-01122-8
Nagy, A., & Alhatlani, B. (2021). An overview of current COVID-19 vaccine platforms. Computational and Structural Biotechnology Journal, 19, 2508-2517. https://doi.org/10.1016/j.csbj.2021.04.061
Nigeria CDC. (2022). Covid-19 Nigeria,. https://www.cdc.gov.globalhealth Accessed on 20th June, 2023
Ndwandwe, D., & Wiysonge, C. S. (2021). COVID-19 vaccines. Current Opinion in Immunology, 71, 111-116. https://doi.org/10.1016/j.coi.2021.07.003
NPHCDA. (2023). CDC and Nigeria Partner to Respond to COVID-19. https://www.cdc.gov/globalhealth/stories/2023/cdc-nigeria-partner-to-respond-to-covid-19.html Accessed on 19th June, 2023
Odeigah, L. O., Mutalub, Y. B., Agede, O. A., Obalowu, I. A., Aiyetoro, S., & Jimoh, G. A. (2022). Adverse events following COVID-19 vaccination in Kwara State, North-central Nigeria. PLOS Global Public Health, 2(8), e0000835. https://doi.org/10.1371/journal.pgph.0000835
Olu-Abiodun, O., Abiodun, O., & Okafor, N. (2022). COVID-19 vaccination in Nigeria: A rapid review of vaccine acceptance rate and the associated factors. PloS One, 17(5), e0267691. https://doi.org/10.1371/journal.pone.0267691
Oriji, P. C., Allagoa, D. O., Wagio, T. J., Obagah, L., Tekenah, E. S., & Ozori, S. E. (2021). Hesitancy of Covid-19 vaccination among Health Workers (other than Doctors) in a tertiary hospital in South-South, Nigeria. Asian Journal of Research in Infectious Diseases, 7(1), 21-31. https://doi.org/10.9734/AJRID/2021/v7i130207
Parida, S. P., Sahu, D. P., Singh, A. K., Alekhya, G., Subba, S. H., Mishra, A., ... & Patro, B. K. (2022). Adverse events following immunization of COVID‐19 (Covaxin) vaccine at a tertiary care center of India. Journal of Medical Virology, 94(6), 2453-2459. https://doi.org/10.1002/jmv.27655
Riad, A., Pokorná, A., Attia, S., Klugarová, J., Koščík, M., & Klugar, M. (2021). Prevalence of COVID-19 vaccine side effects among healthcare workers in the Czech Republic. Journal of Clinical Medicine, 10(7), 1428. https://doi.org/10.3390/jcm10071428
Rzymski, P., Poniedziałek, B., & Fal, A. (2021). Willingness to receive the booster COVID-19 vaccine dose in Poland. Vaccines, 9(11), 1286. https://doi.org/10.3390/vaccines9111286
Soelar, S. A., & Mustaffa, N. A. (2022). A Mixed-Method Analysis of People’s Perception and Behaviour on Vaccination Program in Online Social Media. Malaysian Journal of Medical Research (MJMR), 6(3), 6-18. https://doi.org/10.31674/mjmr.2022.v6i03.002
Stamm, T. A., Partheymüller, J., Mosor, E., Ritschl, V., Kritzinger, S., Alunno, A., & Eberl, J. M. (2023). Determinants of COVID-19 vaccine fatigue. Nature Medicine, 29(5), 1164-1171. https://doi.org/10.1038/s41591-023-02282-y
Sharma, A., Jain, M., & Vigarniya, M. (2022). Acceptance and adverse effects following COVID-19 vaccination among the health care workers at a health care centre in the most backward district of India. Journal of Family Medicine and Primary Care, 11(6), 3224-3229. https://doi.org/10.4103/jfmpc.jfmpc_2370_21
Tequare, M. H., Abraha, H. E., Adhana, M. T., Tekle, T. H., Belayneh, E. K., Gebresilassie, K. B., ... & Sibhatu, M. K. (2021). Adverse events of Oxford/AstraZeneca's COVID-19 vaccine among health care workers of Ayder Comprehensive Specialized Hospital, Tigray, Ethiopia. IJID Regions, 1, 124-129. https://doi.org/10.1016/j.ijregi.2021.10.013
Tobin, E. A., Okonofua, M., Adeke, A., & Obi, A. (2021). Willingness to accept a COVID-19 vaccine in Nigeria: a population-based cross-sectional study. Central African Journal of Public Health, 7(2), 53. https://doi.org/10.11648/j.cajph.20210702.12
Wesselink, A. K., Hatch, E. E., Rothman, K. J., Wang, T. R., Willis, M. D., Yland, J., ... & Wise, L. A. (2022). A prospective cohort study of COVID-19 vaccination, SARS-CoV-2 infection, and fertility. American Journal of Epidemiology, 191(8), 1383-1395. https://doi.org/10.1093/aje/kwac011
World Health Organization (WHO). (2021). Vaccine Tracker and Landscape. Accessed on https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines#:~:text=The%20COVID%2D19%20vaccine%20tracker,their%20progress%20through%20the%20pipeline . Accessed on 12th June, 2023
World Health Organization (WHO). (2022). Adverse Events Following Immunization. https://www.who.int/publications/m/item/reporting-form-aefi . Accessed on 19th June, 2023
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 The Malaysian Journal of Nursing (MJN)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
